Who owns TSCAN THERAPEUTICS INC?
- Ticker: TCRX
- CUSIP Number: 89854m101
Tip: Access positions for across all investors
Analyze quarterly positions in Tscan Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Tscan Therapeutics stock
Who bought or sold TSCAN THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Lynx1 Capital Management | 5.2M | $31M | 0% | Dec 2023 |
|
| EcoR1 Capital | 5.0M | $29M | 0% | Dec 2023 |
|
| BVF | 3.0M | $17M | 0% | Dec 2023 |
|
| Baker Bros. Advisors | 2.8M | $16M | 0% | Dec 2023 |
|
| Propel Bio Management | 2.1M | $12M | 100% | Dec 2023 |
|
| Vanguard Group | 1.8M | $10M | 2% | Dec 2023 |
|
| Deer Management | 1.2M | $7.3M | 0% | Dec 2023 |
|
| Alphabet | 1.1M | $6.3M | 0% | Dec 2023 |
|
| Simplify Asset Management | 1.0M | $6.1M | 0% | Dec 2023 |
|
| Standard Life Aberdeen | 200k | $1.2M | 100% | Dec 2023 |
|
| Stifel Financial | 120k | $702k | 3% | Dec 2023 |
|
| Marshall Wace | 111k | $645k | 100% | Dec 2023 |
|
| Millennium Management | 99k | $578k | 100% | Dec 2023 |
|
| NewEdge Wealth | 92k | $533k | 0% | Dec 2023 |
|
| Jane Street | 84k | $488k | 100% | Dec 2023 |
|
| Citigroup | 73k | $427k | 100% | Dec 2023 |
|
| Laurion Capital Management | 60k | $352k | 100% | Dec 2023 |
|
| Man Group | 50k | $294k | 100% | Dec 2023 |
|
| Balyasny Asset Management | 46k | $268k | 100% | Dec 2023 |
|
| 683 Capital Management | 43k | $252k | 100% | Dec 2023 |
|
| Bank of America Corporation | 38k | $220k | 18802% | Dec 2023 |
|
| Jpmorgan Chase & Co | 33k | $194k | 100% | Dec 2023 |
|
| Goldman Sachs Group | 30k | $177k | 100% | Dec 2023 |
|
| Cubist Systematic Strategies | 26k | $153k | 100% | Dec 2023 |
|
| Charles Schwab Investment Management | 22k | $129k | 100% | Dec 2023 |
|
| Letko, Brosseau & Associates | 21k | $121k | -36% | Dec 2023 |
|
| Virtu Financial | 18k | $107k | 100% | Dec 2023 |
|
| Walleye Trading Advisors | 18k | $104k | 100% | Dec 2023 |
|
| Cannon Global Investment Management | 18k | $139k | 100% | Mar 2024 |
|
| Bank of New York Mellon | 17k | $97k | 100% | Dec 2023 |
|
| Cambridge Investment Research Advisors | 10k | $80k | 100% | Mar 2024 |
|
| Waldron | 10k | $58k | 0% | Dec 2023 |
|
| Aries Wealth Management | 10k | $58k | 0% | Dec 2023 |
|
| Lazard Asset Management | 4.0k | $0 | 100% | Dec 2023 |
|
| UBS Group | 1.4k | $8.3k | 28% | Dec 2023 |
|
| Wells Fargo & Company | 301.00 | $1.8k | 5% | Dec 2023 |
|
| Atlas Capital Advisors | 18.00 | $142.000200 | -98% | Mar 2024 |
|